文献速递肿瘤 PET/CT

胸片/头颈MRI、胸部CT/头颈MRI与18F-FDG PET/CT在口腔、咽及喉癌远处转移与同时性肿瘤检测中的头对头比较

Head-to-Head Comparison of Chest X-Ray/Head and Neck MRI, Chest CT/Head and Neck MRI, and 18F-FDG PET/CT for Detection of Distant Metastases and Synchronous Cancer in Oral, Pharyngeal, and Laryngeal Cancer.
PubMed 文献 · J Nucl Med · 2017-06-01

前瞻性配对队列研究纳入307例经组织学证实的头颈部鳞状细胞癌患者,在同一天且活检前完成胸片/头颈MRI、胸部CT/头颈MRI及18F-FDG PET/CT检查,由独立团队盲法判读,比较三种策略对远处转移和同时性肿瘤的真实检出率。

要点

  • PET/CT检出远处转移18例(6%),高于胸片/MRI的3例(1%)和胸部CT/MRI的11例(4%),绝对差异5%和2%均有统计学意义。
  • PET/CT检出同时性肿瘤25例(8%),显著多于胸片/MRI的3例(1%)和胸部CT/MRI的6例(2%)。
  • PET/CT对远处转移或同时性肿瘤的真实检出率为13%(40例),显著高于胸片/MRI的2%(6例)和胸部CT/MRI的6%(17例)。

核心结论

  • 基于PET/CT的影像策略对远处转移或同时性肿瘤的检出率显著高于现行临床影像指南中的策略,欧洲指南主要推荐胸片/头颈MRI,而美国指南对头颈部鳞状细胞癌患者更倾向于胸部CT/头颈MRI。

研究设计与样本

  • 前瞻性配对队列研究,连续纳入2013年9月至2016年3月期间在欧登塞大学医院经组织学证实的原发性头颈部鳞状细胞癌患者。
  • 纳入患者在同一天且活检前接受胸片/头颈MRI、胸部CT/头颈MRI及18F-FDG PET/CT检查。
  • 扫描由经验丰富的核医学医师或放射科医师组成的独立团队盲法判读。
  • 共纳入307例患者,评估胸片/头颈MRI、胸部CT/头颈MRI和PET/CT对远处转移和同时性肿瘤的真实检出率。

主要发现

  • 胸片/头颈MRI正确检出3例(1%)远处转移患者,胸部CT/头颈MRI检出11例(4%),PET/CT检出18例(6%)。
  • PET/CT与胸片/头颈MRI的绝对差异为5%,与胸部CT/头颈MRI的绝对差异为2%,均具有统计学意义,支持PET/CT。
  • PET/CT正确检出25例(8%)同时性肿瘤,显著多于胸片/头颈MRI的3例(1%)和胸部CT/头颈MRI的6例(2%)。
  • PET/CT对远处转移或同时性肿瘤的真实检出率为13%(40例),显著高于胸片/头颈MRI的2%(6例)和胸部CT/头颈MRI的6%(17例)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The purpose of this study was to determine the detection rate of distant metastasis and synchronous cancer, comparing clinically used imaging strategies based on chest x-ray + head and neck MRI (CXR/MRI) and chest CT + head and neck MRI (CHCT/MRI) with 18F-FDG PET/CT upfront in the diagnostic workup of patients with oral, pharyngeal, or laryngeal cancer. Methods: This was a prospective cohort study based on paired data. Consecutive patients with histologically verified primary head and squamous cell carcinoma at Odense University Hospital from September 2013 to March 2016 were considered for the study. Included patients underwent CXR/MRI and CHCT/MRI as well as PET/CT on the same day and before biopsy. Scans were read masked by separate teams of experienced nuclear physicians or radiologists. The true detection rate of distant metastasis and synchronous cancer was assessed for CXR/MRI, CHCT/MRI, and PET/CT. Results: A total of 307 patients were included. CXR/MRI correctly detected 3 (1%) patients with distant metastasis, CHCT/MRI detected 11 (4%) patients, and PET/CT detected 18 (6%) patients. The absolute differences of 5% and 2%, respectively, were statistically significant in favor of PET/CT. Also, PET/CT correctly detected 25 (8%) synchronous cancers, which was significantly more than CXR/MRI (3 patients, 1%) and CHCT/MRI (6 patients, 2%). The true detection rate of distant metastasis or synchronous cancer with PET/CT was 13% (40 patients), which was significantly higher than 2% (6 patients) for CXR/MRI and 6% (17 patients) for CHCT/MRI. Conclusion: A clinical imaging strategy based on PET/CT demonstrated a significantly higher detection rate of distant metastasis or synchronous cancer than strategies in current clinical imaging guidelines, of which European ones primarily recommend CXR/MRI, whereas U.S. guidelines preferably point to CHCT/MRI in patients with head and neck squamous cell carcinoma.

来源:J Nucl Med,查看原文。版权归原作者所有。

引用

  1. Rohde M, Nielsen AL, Johansen J, et al. Head-to-Head Comparison of Chest X-Ray/Head and Neck MRI, Chest CT/Head and Neck MRI, and 18F-FDG PET/CT for Detection of Distant Metastases and Synchronous Cancer in Oral, Pharyngeal, and Laryngeal Cancer. J Nucl Med. 2017. PMID: 28572489. doi:10.2967/jnumed.117.189704

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。